Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ciurea, Adrian"'
Autor:
Mischlinger, Johannes, Jaeger, Veronika K, Ciurea, Adrian, Gabay, Cem, Hasler, Paul, Mueller, Ruediger B, Siegrist, Claire Ann, Villiger, Peter, Walker, Ulrich A, Hatz, Christoph, Bühler, Silja
Publikováno v:
Vaccine. 40(33)
Many vaccines demonstrate high effectiveness for years. This prospective multicentre study was conducted in Switzerland to assess the long-term persistence of antibodies to the diphtheria/tetanus (dT)-vaccine in adult patients with rheumatic diseases
Autor:
Lamacchia, Céline, Courvoisier, Delphine, Jarlborg, Matthias, Bas, Sylvette, Roux-Lombard, Pascale, Möller, Burkhard, Ciurea, Adrian, Finckh, Axel, Bentow, Chelsea, Martinez-Prat, Laura, Mahler, Michael, Gabay, Cem, Nissen, Michaël, SCQM Rheumatologists
Publikováno v:
Rheumatology, No keab050 (2021)
Objectives The objective of this study was to analyse the predictive value of anti-carbamylated protein (anti-CarP) and anti-peptidyl-arginine deiminase type-3 (anti-PAD3) antibodies, alone or in combination with RF and ACPA, to identify patients at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98b58192a23bfd04d86a2196b36d6e86
https://archive-ouverte.unige.ch/unige:148565
https://archive-ouverte.unige.ch/unige:148565
Autor:
Cecchinato, Valentina, D'Agostino, Gianluca, Raeli, Lorenzo, Nerviani, Alessandra, Schiraldi, Milena, Danelon, Gabriela, Manzo, Antonio, Thelen, Marcus, Ciurea, Adrian, Bianchi, Marco E., Rubartelli, Anna, Pitzalis, Costantino, Uguccioni, Mariagrazia
Publikováno v:
Frontiers in Immunology
Chemokine synergy-inducing molecules are emerging as regulating factors in cell migration. The alarmin HMGB1, in its reduced form, can complex with CXCL12 enhancing its activity on monocytes via the chemokine receptor CXCR4, while the form containing
Autor:
Molnar, Christoph, Scherer, Almut, Baraliakos, Xenofon, de Hooge, Manouk, Micheroli, Raphael, Exer, Pascale, Kissling, Rudolf O, Tamborrini, Giorgio, Wildi, Lukas M, Nissen, Michael J, Zufferey, Pascal, Bernhard, Jürg, Weber, Ulrich, Landewé, Robert B M, van der Heijde, Désirée, Ciurea, Adrian, Rheumatologists of the Swiss Clinical Quality Management Program
Publikováno v:
Molnar, C, Scherer, A, Baraliakos, X, de Hooge, M, Micheroli, R, Exer, P, Kissling, R O, Tamborrini, G, Wildi, L M, Nissen, M J, Zufferey, P, Bernhard, J, Weber, U, Landewé, R B M, van der Heijde, D, Ciurea, A & Rheumatologists of the Swiss Clinical Quality Management Program 2018, ' TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity : results from the Swiss Clinical Quality Management cohort ', Annals of the Rheumatic Diseases, vol. 77, no. 1, pp. 63-69 . https://doi.org/10.1136/annrheumdis-2017-211544
Annals of the rheumatic diseases, vol. 77, no. 1, pp. 63-69
Annals of the Rheumatic Diseases, Vol. 77, No 1 (2018) pp. 63-69
Annals of the Rheumatic Diseases, 77(1), 63-69
Annals of the rheumatic diseases, 77(1), 63-69. BMJ Publishing Group
Annals of the rheumatic diseases, vol. 77, no. 1, pp. 63-69
Annals of the Rheumatic Diseases, Vol. 77, No 1 (2018) pp. 63-69
Annals of the Rheumatic Diseases, 77(1), 63-69
Annals of the rheumatic diseases, 77(1), 63-69. BMJ Publishing Group
ObjectivesTo analyse the impact of tumour necrosis factor inhibitors (TNFis) on spinal radiographic progression in ankylosing spondylitis (AS).MethodsPatients with AS in the Swiss Clinical Quality Management cohort with up to 10 years of follow-up an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf092bb5e5c11fd580cecb5d08f6e4a8
https://hdl.handle.net/1887/76082
https://hdl.handle.net/1887/76082
Autor:
Hiller, Aimee, Biedermann, Luc, Fournier, Nicolas, Butter, Matthias, Vavricka, Stephan R, Ciurea, Adrian, Rogler, Gerhard, Scharl, Michael, Swiss IBD Cohort Study Group
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0211554 (2019)
PLoS ONE
PloS one, vol. 14, no. 4, pp. e0211554
PLoS ONE
PloS one, vol. 14, no. 4, pp. e0211554
Background/aimsExtraintestinal manifestations (EIM) involving joints, skin, eyes and liver represent an important problem in the treatment of IBD patients. The aim of this study was to identify factors that are associated with the occurrence of joint
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::630cb182391ee41c11d9cd2d5235339c
https://www.zora.uzh.ch/id/eprint/170634/
https://www.zora.uzh.ch/id/eprint/170634/
Autor:
Zufferey, Pascal, Scherer, Almut, Nissen, Michaël, Ciurea, Adrian, Tamborrini, Giorgio, Brulhart, Laure Sophie, Blumhardt, Sandra, Toniolo, Martin, Möller, Burkhard, Ziswiler, Hans-Ruedi, SONAR Group, SCQM Foundation
Publikováno v:
Journal of Rheumatology, Vol. 45, No 7 (2018) pp. 887-894
Objective.Several studies have suggested that patients with rheumatoid arthritis (RA) presenting with ultrasound (US) synovitis despite clinical remission have more subsequent flares than those who show both clinical and sonographic remission. The ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9d51dcf012fec44f5e22c98aade663f
Autor:
Nissen, Michael John, Ciurea, Adrian, Bernhard, Jürg, Tamborrini, Giorgio, Mueller, Ruediger, Weiss, Bettina, Toniolo, Martin, Exer, Pascale, Gabay, Cem, Finckh, Axel
Publikováno v:
Arthritis & Rheumatology (Hoboken), Vol. 68, No 9 (2016) pp. 2141-50
To explore the effect of comedication with conventional synthetic disease-modifying antirheumatic drugs (DMARDs) on drug retention and clinical effectiveness of tumor necrosis factor inhibitors (TNFi) in patients with axial spondyloarthritis (SpA).Th
Autor:
Burkhard Möller, Monika Hebeisen, Xenofon Baraliakos, Michael John Nissen, Pascale Exer, Kristina Bürki, Raphael Micheroli, Pascal Zufferey, Adrian Ciurea, Robert Landewé, Almut Scherer, Manouk de Hooge, Désirée van der Heijde
Publikováno v:
PLoS ONE
PLOS ONE
PLoS ONE, 15(3):e0230268. Public Library of Science
PLoS ONE, Vol 15, Iss 3, p e0230268 (2020)
PLoS ONE, 15(3). PUBLIC LIBRARY SCIENCE
Hebeisen, Monika; Micheroli, Raphael; Scherer, Almut; Baraliakos, Xenofon; de Hooge, Manouk; van der Heijde, Désirée; Landewé, Robert; Bürki, Kristina; Nissen, Michael J; Möller, Burkhard; Zufferey, Pascal; Exer, Pascale; Ciurea, Adrian (2020). Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort. PLoS ONE, 15(3), e0230268. Public Library of Science 10.1371/journal.pone.0230268
PLOS ONE
PLoS ONE, 15(3):e0230268. Public Library of Science
PLoS ONE, Vol 15, Iss 3, p e0230268 (2020)
PLoS ONE, 15(3). PUBLIC LIBRARY SCIENCE
Hebeisen, Monika; Micheroli, Raphael; Scherer, Almut; Baraliakos, Xenofon; de Hooge, Manouk; van der Heijde, Désirée; Landewé, Robert; Bürki, Kristina; Nissen, Michael J; Möller, Burkhard; Zufferey, Pascal; Exer, Pascale; Ciurea, Adrian (2020). Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort. PLoS ONE, 15(3), e0230268. Public Library of Science 10.1371/journal.pone.0230268
Objective To investigate whether spinal radiographic progression relates to structural damage at the sacroiliac level in axial spondyloarthritis (axSpA). Methods Patients classified as nonradiographic (nr-) and radiographic (r-) axSpA in the Swiss Cl
Autor:
Pascale Exer, Giorgio Tamborrini, Pascal Zufferey, Burkhard Möller, Adrian Ciurea, Monika Hebeisen, Michael John Nissen, Raphael Micheroli, Almut Scherer
Publikováno v:
PLoS ONE
PloS one, vol. 14, no. 5, pp. e0216746
PLoS ONE, Vol 14, Iss 5, p e0216746 (2019)
Hebeisen, Monika; Scherer, Almut; Micheroli, Raphael; Nissen, Michael J; Tamborrini, Giorgio; Möller, Burkhard; Zufferey, Pascal; Exer, Pascale; Ciurea, Adrian (2019). Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis. PLoS ONE, 14(5), e0216746. Public Library of Science 10.1371/journal.pone.0216746
PLOS ONE, Vol. 14, No 5 (2019) P. e0216746
PloS one, vol. 14, no. 5, pp. e0216746
PLoS ONE, Vol 14, Iss 5, p e0216746 (2019)
Hebeisen, Monika; Scherer, Almut; Micheroli, Raphael; Nissen, Michael J; Tamborrini, Giorgio; Möller, Burkhard; Zufferey, Pascal; Exer, Pascale; Ciurea, Adrian (2019). Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis. PLoS ONE, 14(5), e0216746. Public Library of Science 10.1371/journal.pone.0216746
PLOS ONE, Vol. 14, No 5 (2019) P. e0216746
ObjectivesTo compare drug survival in patients with axial spondyloarthritis treated with different TNF inhibitors in standard dosage.MethodsPatients fulfilling the Assessment in SpondyloArthritis international Society classification criteria for axia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::208a397e0780c903991f23ed688df78f
Autor:
Peter M. Villiger, Désirée van der Heijde, Regula Neuenschwander, Monika Hebeisen, Michael John Nissen, Ulrich Weber, Raphael Micheroli, Robert Landewé, Irene E. van der Horst-Bruinsma, Almut Scherer, Pascale Exer, Axel Finckh, Giorgio Tamborrini, Lukas M Wildi, Jürg Bernhard, Joachim Sieper, Adrian Ciurea, Pascal Zufferey
Publikováno v:
Journal of rheumatology, 45(4), 506-512. Journal of Rheumatology
Swiss Clinical Quality Management Program 2018, ' Response to tumor necrosis factor inhibition in male and female patients with ankylosing spondylitis: Data from a Swiss Cohort ', Journal of Rheumatology, vol. 45, no. 4, pp. 506-512 . https://doi.org/10.3899/jrheum.170166
Journal of Rheumatology, Vol. 45, No 4 (2018) pp. 506-512
Swiss Clinical Quality Management Program 2018, ' Response to tumor necrosis factor inhibition in male and female patients with ankylosing spondylitis : Data from a Swiss Cohort ', Journal of Rheumatology, vol. 45, no. 4, pp. 506-512 . https://doi.org/10.3899/jrheum.170166
Journal of Rheumatology, 45(4), 506-512
Journal of Rheumatology, 45(4), 506-512. Journal of Rheumatology
Swiss Clinical Quality Management Program 2018, ' Response to tumor necrosis factor inhibition in male and female patients with ankylosing spondylitis: Data from a Swiss Cohort ', Journal of Rheumatology, vol. 45, no. 4, pp. 506-512 . https://doi.org/10.3899/jrheum.170166
Journal of Rheumatology, Vol. 45, No 4 (2018) pp. 506-512
Swiss Clinical Quality Management Program 2018, ' Response to tumor necrosis factor inhibition in male and female patients with ankylosing spondylitis : Data from a Swiss Cohort ', Journal of Rheumatology, vol. 45, no. 4, pp. 506-512 . https://doi.org/10.3899/jrheum.170166
Journal of Rheumatology, 45(4), 506-512
Journal of Rheumatology, 45(4), 506-512. Journal of Rheumatology
Objective.To investigate sex differences in connection with the effectiveness of tumor necrosis factor inhibitors (TNFi) in patients with ankylosing spondylitis (AS).Methods.A total of 440 patients with AS (294 men; 146 women) initiating a first TNFi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae98be2e02b1296ab29a49dc0183a0b9
https://pure.amc.nl/en/publications/response-to-tumor-necrosis-factor-inhibition-in-male-and-female-patients-with-ankylosing-spondylitis-data-from-a-swiss-cohort(47953ad4-feff-4d97-a8d7-09f458a1e720).html
https://pure.amc.nl/en/publications/response-to-tumor-necrosis-factor-inhibition-in-male-and-female-patients-with-ankylosing-spondylitis-data-from-a-swiss-cohort(47953ad4-feff-4d97-a8d7-09f458a1e720).html